Vium
Acquired
The digital vivarium for preclinical research
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2013
- Business Model
- B2B
- Website
- vium.com
- Total Funding
- $24.0M
- Last Round
- $24.0M Series BJun 2018
About
Vium is a biotechnology company that built the first fully digital end-to-end Digital Vivarium platform, using computer vision, machine learning, and sensor technologies to non-invasively transform preclinical in vivo drug research. Founded in 2013 as Mousera by Timothy Robertson and Joe Betts-Lacroix, Vium developed digital biomarkers to accelerate drug discovery and improve animal welfare in research settings. The company was acquired by Recursion Pharmaceuticals in July 2020.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account